Investor Alert

New York Markets Close in:

Rigel Pharmaceuticals Inc.

NAS: RIGL

GO
/marketstate/country/us

Market open

 --Real time quotes

Oct 22, 2021, 9:59 a.m.

/zigman2/quotes/207222917/composite

$

3.20

Change

-0.08 -2.55%

Volume

Volume 273,453

Real time quotes

/zigman2/quotes/207222917/composite

Previous close

$ 3.28

$ 3.20

Change

-0.08 -2.55%

Day low

Day high

$3.20

$3.25

Open

52 week low

52 week high

$2.36

$5.50

Open

Insider Actions for Rigel Pharmaceuticals Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
05/19/2021 Bradford S. Goodwin
Director
25,000   Award at $0 per share. 0
05/19/2021 Walter H. Moos
Director
25,000   Award at $0 per share. 0
05/19/2021 Gregg Anthony Lapointe
Director
25,000   Award at $0 per share. 0
05/19/2021 Keith A. Katkin
Director
25,000   Award at $0 per share. 0
05/19/2021 Gary A. Lyons
Director
25,000   Award at $0 per share. 0
05/19/2021 Jane Wasman
Director
25,000   Award at $0 per share. 0
05/19/2021 Brian L. Kotzin
Director
25,000   Award at $0 per share. 0
05/19/2021 Alison L. Hannah
Director
6,250   Award at $0 per share. 0
05/22/2019 Dean L. Schorno
EVP &Chief Financial Officer
3,274   Acquisition at $2.13 per share. 6,973
05/22/2019 Dean L. Schorno
EVP &Chief Financial Officer
46,726   Acquisition at $2.13 per share. 99,526
10/12/2018 Nelson D. Cabatuan
Principal Accounting Officer
10,000   Disposition at $3.12 per share. 31,200
09/17/2018 Anne-Marie S. Duliege
EVP & Chief Medical Officer
37,500   Disposition at $3.5 per share. 131,250
09/17/2018 Anne-Marie S. Duliege
EVP & Chief Medical Officer
115,500   Disposition at $3.5 per share. 404,250
09/17/2018 Anne-Marie S. Duliege
EVP & Chief Medical Officer
37,500   Derivative/Non-derivative trans. at $2.11 per share. 79,125
09/17/2018 Anne-Marie S. Duliege
EVP & Chief Medical Officer
115,500   Derivative/Non-derivative trans. at $2.54 per share. 293,370
09/11/2018 Eldon C. Mayer
EVP & Chief Commercial Officer
50,000   Acquisition at $3.23 per share. 161,500
09/10/2018 Eldon C. Mayer
EVP & Chief Commercial Officer
50,000   Acquisition at $3.28 per share. 164,000
09/04/2018 Anne-Marie S. Duliege
EVP & Chief Medical Officer
16,500   Disposition at $3.51 per share. 57,915
09/04/2018 Anne-Marie S. Duliege
EVP & Chief Medical Officer
16,500   Derivative/Non-derivative trans. at $2.54 per share. 41,910
08/23/2018 Eldon C. Mayer
EVP & Chief Commercial Officer
100,000   Acquisition at $2.82 per share. 282,000
08/17/2018 Raul R. Rodriguez
CEO, President; Director
114,000   Acquisition at $2.63 per share. 299,820
07/02/2018 Anne-Marie S. Duliege
EVP & Chief Medical Officer
5,000   Disposition at $2.79 per share. 13,950

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
0 Purchases
0 Sales
0
0
Last 6 months
8 Purchases
0 Sales
181,250
0
Last 12 months
8 Purchases
0 Sales
181,250
0

Officers and Executives

Mr. Raul R. Rodriguez
President, Chief Executive Officer & Director
Mr. Dean L. Schorno
Chief Financial Officer & Executive Vice President
Dr. Wolfgang Dummer
Chief Medical Officer & Executive Vice President
Mr. David Santos
Chief Commercial Officer & Executive VP
Mr. Joseph Lasaga
Senior Vice President-Corporate Development
Dr. Esteban S. Masuda
Executive Vice President-Research
Ms. Giovanna Matthews
Executive Director-Market Access
Dr. Alison L. Hannah
Director
Ms. Lily Cheung
Vice President-Human Resources
Ms. Dolly A. Vance
Secretary, EVP-Corporate Affairs & General Counsel
Mr. Gary A. Lyons
Chairman
Mr. Bradford S. Goodwin
Independent Director
Dr. Walter H. Moos
Independent Director
Mr. Keith A. Katkin
Independent Director
Dr. Brian L. Kotzin
Independent Director
Mr. Gregg Anthony Lapointe
Independent Director
Ms. Jane Wasman
Independent Director
Trending Tickers
  • /zigman2/quotes/200467500/composite NVDA+6.20%
  • /zigman2/quotes/201948298/composite BABA-5.69%
  • /zigman2/quotes/202092269/composite ENSC+36.10%
  • /zigman2/quotes/200164174/composite SNOA+74.50%
  • /zigman2/quotes/207683784/composite TIGR-10.38%
X
Powered by StockTwits
Link to MarketWatch's Slice.